Smith28 | Prospective observational | ED convenience sample | 34 | E 0.3 mg/kg | Vec 0.01 mg/kg | Sux 1.5–2.0 mg/kg | BP, HR, Sats, myoclonus, sedation | III |
Swanson29 | Retrospective review | Aeromedical setting | 53 | E 0.2–0.4 mg/kg | Lidocaine (12) | Sux (42 patients) | BP | III |
Atropine (3) | | HR | |
| | | | | Vec (3) | | | |
Sovoloke30 | Retrospective review | Urban ED, Patients <10 years | 100 | E 0.37+/–0.15 mg/kg | Lidocaine (58%) | 99% paralytics | BP | III |
Atropine (37%) | (54% Sux) | Need for corticosteroids | |
Schenarts31 | RCT | ED | 31 | E 0.3 mg/kg | Lidocaine or defascic (doctor’s discretion) | Sux 1.0–1.5 mg/kg | Cosyntropin stimulation test | Ib |
M 0.05–0.1 mg/kg | |
Sivilotti32 | DB RCT | ED | 86 | T 5 mg/kg | D-tubocurare or Vec | Sux 1.5 mg/kg | 7 day mortality | Ib |
| | | | F 5 mcg/kg | | | BP/HR, “rapid intubations” | |
| | | | M 0.1 mg/kg | | | |
Woodward33 | Retrospectve review | ED trauma patients | 66 | E 0.2–0.4 mg/kg | No comment | Sux 1–2 mg/kg (51), Vec 0.1–0.3 mg/kg (5) | BP/HR | III |
Johnson34 | Prospective observational | ED | 18 | E 0.3 mg/kg | No comment | No comment | Sedation, BP/HR, “other effects” | III |
Laurin35 | Retrospective review | ED | 54 | E 0.2–0.4 mg/kg | Nil | Sux 1–2 mg/kg | BP/HR | III |
Complications | |
Plewa36 | Prospective observational | ED trauma patients | 20 | E 0.3 mg/kg | Nil | Sux (2) | Attempts, BP/HR, other side effects | III |
Vec (4) | | |
Choi37 | Prospective observational | ED | 121 | E 10–20 mg (45) | Nil | No comment | BP | III |
| | | M 2–4 mg (76) | | | | |